These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36222570)

  • 1. Leveraging a pharmacogenomics knowledgebase to formulate a drug response phenotype terminology for genomic medicine.
    Zhao Y; Brush M; Wang C; Wagner AH; Liu H; Freimuth RR
    Bioinformatics; 2022 Nov; 38(23):5279-5287. PubMed ID: 36222570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplifying the use of pharmacogenomics in clinical practice: Building the genomic prescribing system.
    Danahey K; Borden BA; Furner B; Yukman P; Hussain S; Saner D; Volchenboum SL; Ratain MJ; O'Donnell PH
    J Biomed Inform; 2017 Nov; 75():110-121. PubMed ID: 28963061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics knowledge for personalized medicine.
    Whirl-Carrillo M; McDonagh EM; Hebert JM; Gong L; Sangkuhl K; Thorn CF; Altman RB; Klein TE
    Clin Pharmacol Ther; 2012 Oct; 92(4):414-7. PubMed ID: 22992668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PharmGKB Tutorial for Pharmacogenomics of Drugs Potentially Used in the Context of COVID-19.
    Huddart R; Whirl-Carrillo M; Altman RB; Klein TE
    Clin Pharmacol Ther; 2021 Jan; 109(1):116-122. PubMed ID: 32978778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PharmGKB, an Integrated Resource of Pharmacogenomic Knowledge.
    Gong L; Whirl-Carrillo M; Klein TE
    Curr Protoc; 2021 Aug; 1(8):e226. PubMed ID: 34387941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGxO and PGxLOD: a reconciliation of pharmacogenomic knowledge of various provenances, enabling further comparison.
    Monnin P; Legrand J; Husson G; Ringot P; Tchechmedjiev A; Jonquet C; Napoli A; Coulet A
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):139. PubMed ID: 30999867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics and bioinformatics: PharmGKB.
    Thorn CF; Klein TE; Altman RB
    Pharmacogenomics; 2010 Apr; 11(4):501-5. PubMed ID: 20350130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PharmGKB: the Pharmacogenomics Knowledge Base.
    Thorn CF; Klein TE; Altman RB
    Methods Mol Biol; 2013; 1015():311-20. PubMed ID: 23824865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Text Mining and Development of Pharmacogenomic Knowledge Resource for Precision Medicine.
    Guin D; Rani J; Singh P; Grover S; Bora S; Talwar P; Karthikeyan M; Satyamoorthy K; Adithan C; Ramachandran S; Saso L; Hasija Y; Kukreti R
    Front Pharmacol; 2019; 10():839. PubMed ID: 31447668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using text to build semantic networks for pharmacogenomics.
    Coulet A; Shah NH; Garten Y; Musen M; Altman RB
    J Biomed Inform; 2010 Dec; 43(6):1009-19. PubMed ID: 20723615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer based pharmacogenomics network supported with scientific evidences: from the view of drug repurposing.
    Wang L; Liu H; Chute CG; Zhu Q
    BioData Min; 2015; 8():9. PubMed ID: 25729430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PreMedKB: an integrated precision medicine knowledgebase for interpreting relationships between diseases, genes, variants and drugs.
    Yu Y; Wang Y; Xia Z; Zhang X; Jin K; Yang J; Ren L; Zhou Z; Yu D; Qing T; Zhang C; Jin L; Zheng Y; Guo L; Shi L
    Nucleic Acids Res; 2019 Jan; 47(D1):D1090-D1101. PubMed ID: 30407536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic medicine in Africa: a need for molecular genetics and pharmacogenomics experts.
    Oluwole OG; Henry M
    Curr Med Res Opin; 2023 Jan; 39(1):141-147. PubMed ID: 36094413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics Clinical Annotation Tool (PharmCAT).
    Sangkuhl K; Whirl-Carrillo M; Whaley RM; Woon M; Lavertu A; Altman RB; Carter L; Verma A; Ritchie MD; Klein TE
    Clin Pharmacol Ther; 2020 Jan; 107(1):203-210. PubMed ID: 31306493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating VA's NDF-RT drug terminology with PharmGKB: preliminary results.
    Pathak J; Weiss LC; Durski MJ; Zhu Q; Freimuth RR; Chute CG
    Pac Symp Biocomput; 2012; ():400-9. PubMed ID: 22174295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of incorporating genomic knowledge into electronic medical records for pharmacogenomic clinical decision support.
    Overby CL; Tarczy-Hornoch P; Hoath JI; Kalet IJ; Veenstra DL
    BMC Bioinformatics; 2010 Oct; 11 Suppl 9(Suppl 9):S10. PubMed ID: 21044357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomewide Association Studies in Pharmacogenomics.
    McInnes G; Yee SW; Pershad Y; Altman RB
    Clin Pharmacol Ther; 2021 Sep; 110(3):637-648. PubMed ID: 34185318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
    Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary pharmacogenetic assays in view of the PharmGKB database.
    Tilleman L; Weymaere J; Heindryckx B; Deforce D; Nieuwerburgh FV
    Pharmacogenomics; 2019 Mar; 20(4):261-272. PubMed ID: 30883266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disambiguation of PharmGKB drug-disease relations with NDF-RT and SPL.
    Zhu Q; Freimuth RR; Pathak J; Durski MJ; Chute CG
    J Biomed Inform; 2013 Aug; 46(4):690-6. PubMed ID: 23727027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.